Buying Medicines Online in Indonesia: A BPOM Safety Checklist
A practical BPOM-led checklist for evaluating online medicines in Indonesia, including authorization, labels, expiry, sellers and red flags.
In brief
Before buying medicine online in Indonesia, verify the exact product and seller through current BPOM channels. Apply Cek KLIK: inspect packaging, label, marketing authorization and expiry. Do not rely on a social-media badge, foreign approval, laboratory COA or “research use only” disclaimer as proof that a product is authorized for personal treatment.
What is established—and what is not
- Primary check
- Current BPOM product and authorization records
- Consumer method
- Cek KLIK: packaging, label, authorization and expiry
- Online framework
- BPOM Regulation 14/2024, amended by Regulation 30/2025
- Key uncertainty
- Screenshots and foreign documents may not match the item sold
Five points to keep
- Search the exact product—not just the active ingredient or company name.
- Match brand, dosage form, strength, manufacturer and authorization details.
- Check packaging integrity, Indonesian labeling and expiry on the received item.
- Use licensed clinical and pharmacy channels for prescription treatment.
- Report suspicious products or claims through appropriate BPOM channels.
Why online medicine checks need to be product-specific
A legitimate manufacturer may produce both authorized and unauthorized items, and counterfeiters can copy a familiar brand. Search results, social-media followers and polished packaging are not authorization records. The exact strength, dosage form and manufacturer should align with the current BPOM entry.
If a seller shows an authorization number, search it independently and verify that it resolves to the same product. Do not accept a number that belongs to a supplement, cosmetic or different medicine.
Use BPOM's Cek KLIK method
Cek KLIK is a compact consumer framework: Kemasan (packaging), Label, Izin Edar (marketing authorization) and Kedaluwarsa (expiry). Each step catches a different problem and should be repeated when the item arrives, not only before checkout.
- Packaging: sealed, intact and consistent with the authorized presentation.
- Label: readable product identity, composition, instructions, warnings, manufacturer and required Indonesian information.
- Marketing authorization: current, searchable and matched to the exact item.
- Expiry: legible, plausible and not altered or covered by a new sticker.
Online seller red flags
Be cautious when a seller promises prescription outcomes without assessment, refuses to identify the product, communicates only through an unverified account with no traceable business or pharmacy identity, or tells buyers that an RUO label makes self-use legal. A dramatic discount, “no side effects” claim or urgency countdown should increase scrutiny, not reduce it.
A COA can provide analytical information but does not replace marketing authorization, legitimate dispensing or clinical oversight. Likewise, FDA approval in the United States does not establish BPOM approval in Indonesia.
What to do with a suspicious product
Do not use a product that appears tampered with, mismatched or unverifiable. Preserve the listing, receipt, packaging, lot and photographs. Contact the relevant seller and regulator, and seek medical attention for suspected adverse effects. A healthcare professional can help document the event and identify urgent warning signs.
Research compounds require an even clearer boundary
A laboratory research product should remain in a qualified research setting. Sellers and buyers should not use the research category as a shortcut around medicine controls. If the intent is personal treatment, move to a legitimate clinical pathway with an authorized product.
Common questions, careful answers
How do I check a BPOM number?
Use BPOM's current official search tools and match the complete product details, rather than trusting a screenshot supplied by the seller.
Is a foreign-approved medicine automatically legal to buy online in Indonesia?
No. Indonesian authorization and distribution rules apply independently.
Does research-use-only labeling make personal use acceptable?
No. A disclaimer does not convert a laboratory material into an authorized medicine or remove applicable rules.
Evidence, standards and regulatory sources
- BPOM Cek KLIK ↗Badan POM
- BPOM product-registration search ↗Badan POM
- BPOM Regulation 14/2024 ↗Badan POM legal information network
- BPOM Regulation 30/2025 ↗Badan POM legal information network
- FDA concerns with unapproved GLP-1 drugs ↗U.S. Food and Drug Administration
Continue the evidence trail.
Related guides deepen the distinction between mechanism, analytical quality, approval and human evidence.